6 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| BIOHENG THERAPEUTICS LIMITED | 5 |
| Yibin Libode New Material Co., Ltd. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18263439 | NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | BIOHENG THERAPEUTICS LIMITED | STEIN, LEAH ELIZABETH | 1641 | Non-Final OA | Jul 28, 2023 |
| 18260905 | ROR1-TARGETING ANTIBODY AND USE THEREOF | BIOHENG THERAPEUTICS LIMITED | HOLTZMAN, KATHERINE ANN | 1646 | Non-Final OA | Jul 10, 2023 |
| 18255049 | CD19-TARGETING HUMANIZED ANTIBODY AND USE THEREOF | BIOHENG THERAPEUTICS LIMITED | DUFFY, BRADLEY | 1643 | Non-Final OA | May 30, 2023 |
| 18034177 | CHIMERIC ANTIGEN RECEPTOR TARGETING CD7 AND USE THEREOF | BIOHENG THERAPEUTICS LIMITED | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Apr 27, 2023 |
| 18034167 | BCMA-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF | BIOHENG THERAPEUTICS LIMITED | HOWARD, ZACHARY C | 1674 | Non-Final OA | Apr 27, 2023 |
| 18304044 | LOW-RESIDUAL-ALKALI HIGH-NICKEL TERNARY POSITIVE-ELECTRODE MATERIAL AS WELL AS PREPARATION METHOD AND USE THEREOF | Yibin Libode New Material Co., Ltd. | HANSEN, JARED A | 1723 | Non-Final OA | Apr 20, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial